By ETF Desk
Manipal Health, a leading healthcare conglomerate, received official approval from the Securities and Exchange Board of India (SEBI) to proceed with its initial public offering (IPO), aimed at raising Rs 10,000 crore (approximately USD 1.3 billion). The announcement was made on a Wednesday and signals the company's intent to strengthen its financial base as it expands services across Karnataka and beyond.
Founded in the early 1990s, Manipal Health has grown from a single specialty hospital into a network of over 30 facilities, including a flagship cancer center in Udupi District that serves patients from across South India. The IPO will enable the firm to invest in advanced medical technologies, expand its rural outreach programmes, and meet regulatory requirements for higher capital reserves. Investors can apply through listed banks and brokers between July 25 – 28, 2026, with pricing expected above the 30‑day average of Rs 305 per share.
The approval from SEBI is a major boost for the Indian healthcare market, which is projected to reach a size of over Rs 18.8 trillion by 2030. By listing, Manipal Health will join a few large healthcare players such as Apollo Hospitals and Fortis Healthcare, providing institutional investors with exposure to a topic that historically has had limited growth. Source: Google News – Manipal.